Maj bank Image empty

The Ritedose Corporation

The Ritedose Corporation (TRC) offers outsourced development and manufacturing services for ophthalmology drugs, respiratory drugs, and vaccines. TRC also develops and markets its own portfolio of generic drugs with a particular focus on critical medicines in short supply.

Investment rationale 

US market leader in the attractive blow-fill-seal CDMO market, boasting more than 1.5x the capacity of its nearest competitor and a tenured, blue-ship customer base.  Attractive business model with a double-digit annual growth in organic sales since 2007 and high cash conversion.

Headquarters: Columbia, USA


Fund: MIM I


Year of investment


Maj bank Image empty